Professors Guan Yi and Joseph Sriyal Malik Peiris, both distinguished scholars of the Li Ka Shing Faculty of Medicine, The University of Hong Kong, and members of SJCEIRS, have been awarded the prestigious John Dirks Canada Gairdner Global Health Award. They were awarded for “significantly contributing to understanding the origins and options for control of… Read more »
News
Introducing CEIRR – A New Influenza Research Network funded by NIAID
The National Institute of Allergy and Infectious Disease (NIAID) have announced a new Influenza Research Network, called the Centers of Excellence for Influenza Research and Response (CEIRR). Funding for the first year of contracts totaled approximately $24 million and NIAID expects to support the contract for 7 years. CEIRR will replace the Centers of Excellence… Read more »
Dr. Benjamin Miller’s Research Chosen as Editors’ Choice by ACS Publications
Last month, CEIRS member Dr. Benjamin Miller’s article was chosen as Editors’ Choice by ACS Publications. Dr. Miller is a Professor in both the Department of Dermatology and the Department of Biochemistry and Biophysics at the University of Rochester Medical Center School of Medicine and Dentistry, a member of the New York Influenza Center of… Read more »
CEIRS Network Collaboratively Performs Risk Assessment for Emerging Canine H3 Influenza Viruses: Lessons Learned for Future Pandemic Response
NIAID CEIRS | Research Publication Commentary Martinez-Sobrido L et al. (2020) Characterizing Emerging Canine H3 Influenza Viruses. PLoS Pathogens. 16(4):e1008409. doi: 10.1371/journal.ppat.1008409. The NIAID Centers of Excellence for Influenza Research and Surveillance (CEIRS) Network was established in 2007 in response to the 2005 HHS Pandemic Influenza Response & Preparedness Plan. The aim of the CEIRS Network, in addition to the ongoing influenza surveillance and… Read more »
CRIP Researcher Publishes Collaborative Study on SARS-CoV-2 Variant
For the last several weeks, the news has been dominated not only by updates on the COVID-19 vaccine but also by a potential mutation in the SARS-CoV-2 virus. There is significant public concern about this variant, which emerged in Europe several months ago and was named D614G, but little research has been published thus far. A recent article in Science Magazine features a collaborative project between University of North Carolina at Chapel Hill and University of Wisconsin-Madison analyzing the effects of the mutation.
CEIRS Researchers Review the Effects of the Microbiome on Vaccination
An individual’s microbiome plays a big part in every aspect of their health. CEIRS researchers reviewed the implications the microbiome may have on vaccine efficacy.
SJCEIRS Researcher Featured on NPR
Dr. Stacey Schultz-Cherry, a leading researcher at St. Jude CEIRS, was included in an interview with NPR science correspondent Joe Palca about approval for the Moderna COVID-19 vaccine. The interview focused on the science behind vaccine development and the approval requirements. New COVID-19 vaccines are being approved by the FDA through a process called an “emergency use authorization” in order to get them to vulnerable populations more quickly, so… Read more »
CEIRS Researchers Publish Promising Data from Universal Influenza Vaccine Clinical Trial
The efficacy of the flu vaccine has long been an area of interest for researchers. Because of the high rate of mutations between influenza strains, the vaccines developed annually may not always match the prevailing strain that is circulating in the population. This is problematic from a public health perspective and may lead to a… Read more »
CRIP Investigators Publish Key SARS-CoV-2 Seroprevalence Findings
Several investigators from the Center for Research on Influenza Pathogenesis (CRIP), including Drs. Daniel Stadlbauer, Harm van Bakel, and Florian Krammer, completed a retrospective analysis of SARS-CoV-2 seroprevalence in New York City that has been accepted for publication by Nature. The study is based on a large and demographically diverse dataset that was assessed over several months during the first wave of… Read more »
International Collaboration Identifies Biological Markers of COVID-19 Severity
Most people infected with COVID-19 only have mild or moderate symptoms, but some are much more severe. This study assessed immune response and clinical history from patients at two medical centers in order to compare type and severity of respiratory disease.